NCT00862706View on ClinicalTrials.gov

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Compensated Chronic Hepatitis B
Interventions
DRUG

Telbivudine/LDT600A

Oral once daily

Trial Locations (6)

11358

Hepatobiliary Associates of New York, Bayside

60612

Rush University Medical Center, Chicago

77030

Liver Associates of Texas, Houston

Liver Specialist of Texas, Houston

02111

Tufts Medical Center, Boston

00909

Fundacion de Investigacion de Diego, San Juan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY